Groundbreaking study targets ovarian cancer in black women
NCT ID NCT06412120
Summary
This study aims to understand how a maintenance drug called niraparib works in women of African ancestry who have ovarian cancer. Researchers want to see if genetic background affects the drug's safety, side effects, and how the body processes it. The goal is to help control the cancer and prevent it from coming back after initial treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Broward Health
RECRUITINGFort Lauderdale, Florida, 33316, United States
Contact Email: •••••@•••••
Contact
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.